U.S. markets close in 4 hours 36 minutes
  • S&P 500

    +81.66 (+1.98%)
  • Dow 30

    +554.55 (+1.69%)
  • Nasdaq

    +317.25 (+2.54%)
  • Russell 2000

    +49.69 (+2.60%)
  • Crude Oil

    -1.31 (-1.45%)
  • Gold

    +3.00 (+0.17%)
  • Silver

    +0.26 (+1.26%)

    +0.0135 (+1.33%)
  • 10-Yr Bond

    -0.0530 (-1.89%)

    +0.0177 (+1.47%)

    -2.7360 (-2.02%)

    +828.58 (+3.58%)
  • CMC Crypto 200

    +33.20 (+6.25%)
  • FTSE 100

    +15.38 (+0.21%)
  • Nikkei 225

    -180.63 (-0.65%)

One Kewaunee Scientific Corporation (NASDAQ:KEQU) insider upped their stake by 6.8% in the previous year

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

From what we can see, insiders were net buyers in Kewaunee Scientific Corporation's (NASDAQ:KEQU ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it.

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

See our latest analysis for Kewaunee Scientific

The Last 12 Months Of Insider Transactions At Kewaunee Scientific

In the last twelve months, the biggest single purchase by an insider was when insider Peter Kamin bought US$113k worth of shares at a price of US$13.08 per share. So it's clear an insider wanted to buy, at around the current price, which is US$14.06. Of course they may have changed their mind. But this suggests they are optimistic. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. In this case we're pleased to report that the insider bought shares at close to current prices. Peter Kamin was the only individual insider to buy during the last year.

The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!


Kewaunee Scientific is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Does Kewaunee Scientific Boast High Insider Ownership?

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. Insiders own 22% of Kewaunee Scientific shares, worth about US$8.5m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Do The Kewaunee Scientific Insider Transactions Indicate?

It's certainly positive to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. Insiders likely see value in Kewaunee Scientific shares, given these transactions (along with notable insider ownership of the company). So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To help with this, we've discovered 2 warning signs (1 doesn't sit too well with us!) that you ought to be aware of before buying any shares in Kewaunee Scientific.

But note: Kewaunee Scientific may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.